Literature DB >> 21813201

Long-term prognosis of patients with lung cancer detected on low-dose chest computed tomography screening.

Takeshi Nawa1, Tohru Nakagawa, Tetsuya Mizoue, Suzushi Kusano, Tatsuya Chonan, Shimao Fukai, Katsuyuki Endo.   

Abstract

The effectiveness of lung cancer screening using low-dose chest computed tomography (CT) remains elusive. The present study examined the prognosis of patients with lung cancer detected on CT screening in Japanese men and women. Subjects were 210 patients with primary lung cancer identified on CT screening at two medical facilities in Hitachi, Japan, where a total of 61,914 CT screenings were performed among 25,385 screenees between 1998 and 2006. Prognostic status of these patients was sought by examining medical records at local hospitals, supplemented by vital status information from local government. The 5-year survival rate was estimated according to the characteristics of patients and lung nodule. A total of 203 (97%) patients underwent surgery. During a 5.7-year mean follow-up period, 19 patients died from lung cancer and 6 died from other causes. The estimated 5-year survival rate for all patients and for those on stage IA was 90% and 97%, respectively. Besides cancer stage, smoking and nodule appearance were independent predictors of a poor survival; multivariable-adjusted hazard ratio (95% confidence interval) was 4.7 (1.3, 16.5) for current and past smokers versus nonsmokers and 4.6 (1.6, 13.9) for solid nodule versus others. Even patients with solid shadow had a 5-year survival of 82% if the lesion was 20mm or less in size. Results suggest that lung cancers detected on CT screening are mostly curative. The impact of CT screening on mortality at community level needs to be clarified by monitoring lung cancer deaths.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21813201     DOI: 10.1016/j.lungcan.2011.07.002

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  8 in total

1.  Clinical characteristics and prognosis of ground-glass opacity nodules in young patients.

Authors:  Jun Wang; Han Ma; Chong-Jun Ni; Jing-Kang He; Hai-Tao Ma; Jin-Feng Ge
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

2.  A population-based cohort study to evaluate the effectiveness of lung cancer screening using low-dose CT in Hitachi city, Japan.

Authors:  Takeshi Nawa; Keisuke Fukui; Tomio Nakayama; Motoyasu Sagawa; Tohru Nakagawa; Hideo Ichimura; Tetsuya Mizoue
Journal:  Jpn J Clin Oncol       Date:  2019-02-01       Impact factor: 3.019

Review 3.  Landscape on CT screening for lung cancer in Asia.

Authors:  Natthaya Triphuridet; Claudia Henschke
Journal:  Lung Cancer (Auckl)       Date:  2019-09-30

4.  Descriptive study of chest x-ray examination in mandatory annual health examinations at the workplace in Japan.

Authors:  Yuya Watanabe; Toru Nakagawa; Kota Fukai; Toru Honda; Hiroyuki Furuya; Takeshi Hayashi; Masayuki Tatemichi
Journal:  PLoS One       Date:  2022-01-12       Impact factor: 3.240

5.  Clinical features and surgical outcomes of young patients with lung adenocarcinoma manifesting as ground glass opacity.

Authors:  Rirong Qu; Dehao Tu; Yixin Cai; Wei Ping; Xiangning Fu
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

6.  From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF).

Authors:  S Couraud; A B Cortot; L Greillier; V Gounant; B Mennecier; N Girard; B Besse; L Brouchet; O Castelnau; P Frappé; G R Ferretti; L Guittet; A Khalil; P Lefebure; F Laurent; S Liebart; O Molinier; E Quoix; M-P Revel; B Stach; P-J Souquet; P Thomas; J Trédaniel; E Lemarié; G Zalcman; F Barlési; B Milleron
Journal:  Ann Oncol       Date:  2012-11-07       Impact factor: 32.976

7.  Clinical and radiological characteristics of central pulmonary adenocarcinoma: a comparison with central squamous cell carcinoma and small cell lung cancer and the impact on treatment response.

Authors:  Zhe Wang; Minghuan Li; Yong Huang; Li Ma; Hui Zhu; Li Kong; Jinming Yu
Journal:  Onco Targets Ther       Date:  2018-05-04       Impact factor: 4.147

8.  Lung Cancer Screening with Low-Dose CT in Female Never Smokers: Retrospective Cohort Study with Long-term National Data Follow-up.

Authors:  Hyae Young Kim; Kyu-Won Jung; Kun Young Lim; Soo-Hyun Lee; Jae Kwan Jun; Jeongseon Kim; Bin Hwangbo; Jin Soo Lee
Journal:  Cancer Res Treat       Date:  2017-07-17       Impact factor: 4.679

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.